top of page
Looking for a trusted partner to refine your design, achieve regulatory clearance, and launch manufacturing into the global medical market?
The objective of this work is to determine the accuracy and feasibility of a new point of care device called BiliDx to measure total bilirubin concentration in neonates in low-resource settings. BiliDx provides an important tool to monitor the efficacy and progress of phototherapy, ensuring appropriate treatment dosage and duration. Used together, BiliDx and blue light phototherapy have the potential to reduce the morbidity and mortality associated with neonatal jaundice in low resource settings.
bottom of page